Código QR (código de barras bidimensional)

Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes

Sulfonylurea monotherapy is the standard treatment for patients with the most common form of permanent neonatal diabetes, KCNJ11 neonatal diabetes, but it is not always sufficient. For the first time, we present a case of successful use of a GLP-1 receptor agonist as add-on therapy in the treatment...

ver descrição completa

Na minha lista:
Principais autores: Morten Hindsø, Christoffer Martinussen, Maria Saur Svane, Simon Veedfald, Birthe Gade-Rasmussen, Torben Hansen, Sten Madsbad
Formato: Artigo
Idioma:Inglês
Publicado em: SMC MEDIA SRL 2021-03-01
coleção:European Journal of Case Reports in Internal Medicine
Assuntos:
neonatal diabetes
kcnj11
sulfonylurea
glp-1
Acesso em linha:https://www.ejcrim.com/index.php/EJCRIM/article/view/2352
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados